Accessing Lung Cancer Experts from Anywhere in the World

Christian Rolfo, MD, PhD, MBA, Dr.h.c.

Q&A with Lead ALCHEMIST Investigator, Dr. Ramaswamy Govindan

The Peaks and Valleys in Lung Cancer Therapeutics Research

What Can We Offer a Patient with a Malignant Mesothelioma?

2019 IASLC Best of the World Lung Cancer Conference Results in New Virtual Collaboration

Checkpoint Inhibitors and Clinical Decision Making: A Q&A with Dr. Nasser H. Hanna

Scott Antonia, MD, PhD

Charles B. Simone, II, MD

FDA’s New Acting Commissioner

Howard (Jack) West, MD

Lorlatinib’s Role in ROS1-Positive Lung Cancer